24th January 2017
The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.
4th January 2017
In an effort to curb the current wave of recreational synthetic cannabinoids, the Government have introduced new controls for a range of core chemical structures. These structures are also found in many pharmaceuticals and could stifle future pharmaceutical development